SOPHiA GENETICS announced a historic milestone, having analyzed over two million patient genomic profiles on its AI-powered analytics Platform, SOPHiA DDM™. This achievement signifies a doubling of the one million profiles announced less than three years prior, demonstrating accelerated adoption and trust in the platform.
The SOPHiA DDM™ Platform is supported by a global network of over 800 healthcare institutions across 72 countries, which regularly contribute data and expertise. This continuous input of real-world data, with thousands of new oncology and rare disease cases processed daily, ensures the AI-driven insights are deeply rooted in clinical reality.
This milestone solidifies SOPHiA GENETICS' position as a leading provider of actionable insights for patient care, leveraging an unmatched dataset of diverse, real-world patient data. The platform's ability to integrate hundreds of millions of data points across multiple health dimensions is expected to drive even greater impact for precision medicine globally.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.